Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline.
Allen
L
L
Tejera
C
C
D015057:1-Naphthylamine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000188:drug therapy*; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D020280:Sertraline
D015057:1-Naphthylamine; D003024:Clozapine; D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline